Quarterly Transactions Made in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 11,658,810 | 2,931,568 | 14,590,378 | 3,774,404 | 3,411,804 | 7,186,208 | 7,404,170 | |
Q4 2021 | 9,876,329 | 9,917,249 | 19,793,578 | 1,692,510 | 2,576,056 | 4,268,566 | 15,525,012 | |
Q1 2022 | 15,496,588 | 1,759,305 | 17,255,893 | 11,740,901 | 2,041,816 | 13,782,717 | 3,473,176 | |
Q2 2022 | 23,260,659 | 10,083,230 | 33,343,889 | 15,618,565 | 3,330,583 | 18,949,148 | 14,394,741 | |
Q3 2022 | 21,467,660 | 3,314,735 | 24,782,395 | 8,722,485 | 29,411 | 8,751,896 | 16,030,499 | |
Q4 2022 | 13,575,557 | 3,347,906 | 16,923,463 | 7,353,870 | 0 | 7,353,870 | 9,569,593 | |
Q1 2023 | 5,863,341 | 4,159,229 | 10,022,570 | 3,726,120 | 437 | 3,726,557 | 6,296,013 | |
Q2 2023 | 20,886,013 | 6,429,481 | 27,315,494 | 22,457,241 | 378,912 | 22,836,153 | 4,479,341 | |
Q3 2023 | 6,091,700 | 1,357,194 | 7,448,894 | 6,116,870 | 522,410 | 6,639,280 | 809,614 | |
Q4 2023 | 4,832,762 | 3,292,013 | 8,124,775 | 7,506,203 | 0 | 7,506,203 | 618,572 | |
Q1 2024 | 7,336,157 | 2,010,406 | 9,346,563 | 6,403,194 | 0 | 6,403,194 | 2,943,369 | |
Q2 2024 | 3,295,458 | 7,443,088 | 10,738,546 | 7,479,472 | 0 | 7,479,472 | 3,259,074 | |
Q3 2024 | 12,597,531 | 898,542 | 13,496,073 | 10,246,918 | 0 | 10,246,918 | 3,249,155 |